The disruption of protein-protein interactions as a therapeutic strategy for prostate cancer

Bárbara Matos, John Howl, Carmen Jerónimo, Margarida Fardilha*

*Corresponding author for this work

    Research output: Contribution to journalReview articlepeer-review

    13 Citations (SciVal)
    Original languageEnglish
    Article number105145
    JournalPharmacological Research
    Volume161
    DOIs
    Publication statusPublished (VoR) - Nov 2020

    Funding

    We thank the Portuguese Foundation for Science and Technology(FCT) , European Union , QREN , FEDER and COMPETE for funding iBiMED ( UIDB/04501/2020 , POCI-01-0145-FEDER-007628 and UID/BIM/04501/2019 ) and an individual scholarship from BM (SFRH/BD/146032/2019).

    FundersFunder number
    QREN
    European Commission
    Fundação para a Ciência e a Tecnologia
    Programa Operacional Temático Factores de CompetitividadeUID/BIM/04501/2019, POCI-01-0145-FEDER-007628, UIDB/04501/2020

      Keywords

      • Disruption
      • Peptides
      • Prostate cancer
      • Protein-protein interactions
      • Small molecules
      • Treatment

      Fingerprint

      Dive into the research topics of 'The disruption of protein-protein interactions as a therapeutic strategy for prostate cancer'. Together they form a unique fingerprint.

      Cite this